BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15384172)

  • 1. A microarray model system identifies potential new target genes of the proto-oncogene HOX11.
    Hoffmann K; Dixon DN; Greene WK; Ford J; Taplin R; Kees UR
    Genes Chromosomes Cancer; 2004 Dec; 41(4):309-20. PubMed ID: 15384172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple negative elements contribute to repression of the HOX11 proto-oncogene.
    Brake RL; Kees UR; Watt PM
    Oncogene; 1998 Oct; 17(14):1787-95. PubMed ID: 9778044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A complex containing PBX2 contributes to activation of the proto-oncogene HOX11.
    Brake RL; Kees UR; Watt PM
    Biochem Biophys Res Commun; 2002 May; 294(1):23-34. PubMed ID: 12054735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia.
    Riz I; Hawley RG
    Oncogene; 2005 Aug; 24(36):5561-75. PubMed ID: 15897879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
    Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
    Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promoter with bidirectional activity is located between TLX1/HOX11 and a divergently transcribed novel human gene.
    Greene WK; Sontani Y; Sharp MA; Dunn DS; Kees UR; Bellgard MI
    Gene; 2007 Apr; 391(1-2):223-32. PubMed ID: 17303350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hox11 is required to maintain normal Wt1 mRNA levels in the developing spleen.
    Koehler K; Franz T; Dear TN
    Dev Dyn; 2000 May; 218(1):201-6. PubMed ID: 10822272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
    Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
    Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
    Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C
    Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
    Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
    Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG).
    Kees UR; Heerema NA; Kumar R; Watt PM; Baker DL; La MK; Uckun FM; Sather HN
    Leukemia; 2003 May; 17(5):887-93. PubMed ID: 12750702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells.
    Dixon DN; Izon DJ; Dagger S; Callow MJ; Taplin RH; Kees UR; Greene WK
    Br J Haematol; 2007 Jul; 138(1):54-67. PubMed ID: 17555447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming function of the HOX11/TCL3 homeobox gene.
    Hawley RG; Fong AZ; Reis MD; Zhang N; Lu M; Hawley TS
    Cancer Res; 1997 Jan; 57(2):337-45. PubMed ID: 9000579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].
    He J; Chen ZX; Xue YQ; Li JQ; He HL; Huang YP; He YX; Chai YH; Zhu LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):551-3. PubMed ID: 16215946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of FHL1 by TLX1/HOX11 is dosage, cell-type and promoter context-dependent.
    Rice KL; Kees UR; Greene WK
    Biochem Biophys Res Commun; 2008 Mar; 367(3):707-13. PubMed ID: 18073142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M; Prima V; Tung YH; Hunger SP
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of SIX3 homeodomain mutations in holoprosencephaly: interaction with the nuclear receptor NR4A3/NOR1.
    Laflamme C; Filion C; Labelle Y
    Hum Mutat; 2004 Dec; 24(6):502-8. PubMed ID: 15523651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
    Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
    Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
    Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
    Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
    Raetz EA; Perkins SL; Bhojwani D; Smock K; Philip M; Carroll WL; Min DJ
    Pediatr Blood Cancer; 2006 Aug; 47(2):130-40. PubMed ID: 16358311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.